The COVID-19 pandemic has caused an unprecedented public health crisis worldwide. Since the onset of the pandemic, there has been a flurry of research into potential treatments for the disease. One such treatment that has received a lot of attention recently is ivermectin, a medication that is commonly used to treat parasitic infections.

Ivermectin has been promoted as a potential treatment for COVID-19 by some individuals and organizations. However, recent clinical trials and studies have shown that ivermectin is not an effective treatment for non-severe COVID-19 patients. In this article, we will explore the evidence behind these claims and why ivermectin should not be used as a treatment for COVID-19.

What is Ivermectin?

Ivermectin is an anti-parasitic drug that was first developed in the 1970s. It is used to treat a variety of parasitic infections, including river blindness, lymphatic filariasis, and scabies. Ivermectin works by inhibiting the nervous system of parasites, which leads to their death.

Ivermectin has also been used in veterinary medicine to treat parasitic infections in animals. In recent years, there has been interest in using ivermectin as a potential treatment for other diseases, including COVID-19.

Why Has Ivermectin Been Proposed as a Treatment for COVID-19?

The idea that ivermectin could be an effective treatment for COVID-19 emerged in the early days of the pandemic. The drug had been shown to have antiviral properties in vitro, meaning that it had been shown to be effective against viruses in a laboratory setting.

As the pandemic progressed, there were reports of some doctors and researchers using ivermectin to treat COVID-19 patients, particularly in countries like India and Brazil. Some of these individuals reported that the drug had been effective in treating COVID-19 patients.

However, there were also concerns about the quality of the studies that were being conducted and the lack of rigorous clinical trials to support the use of ivermectin as a treatment for COVID-19.

What Do the Clinical Trials Say About Ivermectin as a Treatment for COVID-19?

Since the onset of the pandemic, there have been numerous clinical trials and studies conducted to investigate the potential of ivermectin as a treatment for COVID-19.

One of the most high-profile studies was a systematic review and meta-analysis of 14 randomized controlled trials that was published in the British Medical Journal in August 2021. The study found that there was no statistically significant difference in mortality or clinical improvement between patients who were treated with ivermectin and those who received a placebo.

Other studies have also failed to show that ivermectin is an effective treatment for COVID-19. For example, a study conducted in Argentina found that there was no difference in the clinical outcomes between patients who were treated with ivermectin and those who received a placebo. Similarly, a study conducted in Brazil found that there was no difference in the time it took for patients to recover between those who received ivermectin and those who did not.

Why Shouldn’t Ivermectin Be Used as a Treatment for COVID-19?

There are several reasons why ivermectin should not be used as a treatment for COVID-19.

Firstly, the evidence from clinical trials and studies has consistently shown that ivermectin is not an effective treatment for non-severe COVID-19 patients. While there are some anecdotal reports of individuals who have experienced positive outcomes after being treated with ivermectin, these reports are not supported by rigorous scientific evidence.

Secondly, there are concerns about the safety of using ivermectin as a treatment for COVID-19. While the drug is generally safe when used to treat parasitic infections, the safety of using ivermectin to treat COVID-19 has not been fully established. There have been reports of individuals experiencing adverse reactions to ivermectin when it is used to treat COVID-19, including liver injury and even death.

Thirdly, the promotion of ivermectin as a treatment for COVID-19 has led to shortages of the drug in some countries, which has had negative consequences for individuals who need it to treat parasitic infections. In some cases, individuals have turned to using veterinary formulations of ivermectin, which can be dangerous and potentially fatal.

Finally, the promotion of ivermectin as a treatment for COVID-19 has distracted attention and resources away from other potential treatments and interventions. While it is important to investigate all potential treatments for COVID-19, it is equally important to focus on interventions that have been shown to be effective in clinical trials and studies.

Conclusion

While the idea of using ivermectin as a treatment for COVID-19 may be attractive, the evidence from clinical trials and studies has consistently shown that it is not an effective treatment for non-severe COVID-19 patients. Moreover, there are concerns about the safety of using ivermectin to treat COVID-19, and the promotion of the drug as a treatment has led to shortages and potentially dangerous use.

It is important to continue to investigate all potential treatments for COVID-19, but it is equally important to base treatment decisions on rigorous scientific evidence. As such, healthcare professionals should avoid using ivermectin as a treatment for COVID-19 and instead focus on interventions that have been shown to be effective in clinical trials and studies.

Visit DocMode for Courses and lectures